DEA withdraws kratom ban, opens public comment period

The American Pharmacists Association posted an article titled, “DEA withdraws kratom ban, opens public comment period.” The article reads in part as follows;

“In late August, DEA announced its intention to make kratom a Schedule I drug to avoid what it called “an imminent hazard to public safety.” But after a public outcry and enormous pressure from lawmakers, in October the agency took the unprecedented move of withdrawing its plans to ban kratom, according to a notice posted in the Federal Register.

Instead, DEA is opening a public comment period ending December 1, 2016, before making a final determination, along with formal input from FDA, about scheduling kratom.

Kratom, a medicinal plant containing mitragynine and 7-hydroxymitragynine, has been marketed as a safe and legal alternative to controlled substances to alleviate pain.

DEA initially proposed the Schedule I classification because, according to the agency, kratom has a “high potential for abuse, has no currently accepted medical use in treatment in the United States, and has a lack of accepted safety for use under medical supervision.”

Click here to continue reading.

 

Leave a Reply

Your email address will not be published.

Please Answer: *